| Physicians’ attitudes toward prescribable mHealth apps and implications for adoption in Germany: mixed methods study F Dahlhausen, M Zinner, L Bieske, JP Ehlers, P Boehme, L Fehring JMIR mHealth and uHealth 9 (11), e33012, 2021 | 83 | 2021 |
| Quantum computing's potential for drug discovery: Early stage industry dynamics M Zinner, F Dahlhausen, P Boehme, J Ehlers, L Bieske, L Fehring Drug Discovery Today 26 (7), 1680-1688, 2021 | 76 | 2021 |
| There's an app for that, but nobody's using it: insights on improving patient access and adherence to digital therapeutics in Germany F Dahlhausen, M Zinner, L Bieske, JP Ehlers, P Boehme, L Fehring Digital Health 8, 20552076221104672, 2022 | 55 | 2022 |
| Toward the institutionalization of quantum computing in pharmaceutical research M Zinner, F Dahlhausen, P Boehme, J Ehlers, L Bieske, L Fehring Drug Discovery Today 27 (2), 378-383, 2022 | 35 | 2022 |
| Critical path activities in clinical trial setup and conduct: How to avoid bottlenecks and accelerate clinical trials L Bieske, M Zinner, F Dahlhausen, H Truebel Drug Discovery Today 28 (10), 103733, 2023 | 7 | 2023 |
| Trends, challenges, and success factors in pharmaceutical portfolio management: cognitive biases in decision-making and their mitigating measures L Bieske, M Zinner, F Dahlhausen, H Trübel Drug Discovery Today, 103734, 2023 | 4 | 2023 |
| Going digital in Germany: An exploration of physicians’ attitudes towards the introduction of electronic prescriptions–A mixed methods approach A Graf, L Fehring, M Henningsen, M Zinner International Journal of Medical Informatics 174, 105063, 2023 | 4 | 2023 |
